HER-2/neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared with Fluorescent In Situ Hybridization-Reference-Cited by-同舟云学术

HER-2/neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared with Fluorescent In Situ Hybridization

Published:2001-11 Issue:11 Volume:14 Page:1079-1086
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Thomson Thomas A,Hayes Malcolm M,Spinelli John J,Hilland Ernie,Sawrenko Christina,Phillips Don,Dupuis Beverley,Parker Robin L

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3880440.pdf

Reference19 articles.

1. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707–712.

2. Ross JS, Fletcher JA . HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol 1999; 112 (1 Suppl 1):S53–S67.

3. Paik S, Bryant J, Park C, Fisher B, Tan-Chiu E, Hyams D, et al. erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer [see comments]. J Natl Cancer Inst 1998; 90: 1361–1370.

4. Thor AD, Berry DA, Budman DR, Muss HB, Kute T, Henderson IC, et al. erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer [see comments]. J Natl Cancer Inst 1998; 90: 1346–1360.

5. Ross JS, Fletcher JA . The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells 1998; 16: 413–428.

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of HER2 DAKO HercepTest and Ventana 4B5 immunohistochemical assays on detecting HER2 gene-amplification in uterine serous carcinomas;Human Pathology;2024-06

2. Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases;Breast Cancer Research;2024-02-23

3. Advancements in computer vision and pathology: Unraveling the potential of artificial intelligence for precision diagnosis and beyond;Advances in Cancer Research;2024

4. Color Standardization and Stain Intensity Calibration for Whole Slide Image-Based Immunohistochemistry Assessment;Microscopy and Microanalysis;2023-12-29

5. High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients;Breast Cancer Research;2023-11-09